UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031668
Receipt number R000036169
Scientific Title Individualized intervention by community pharmacists for supporting self-care of diabetic patients: Implementation of the tool predicting poor medication adherence with collaborative interviewing
Date of disclosure of the study information 2018/03/11
Last modified on 2021/03/15 08:43:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Individualized intervention by community pharmacists for supporting self-care of diabetic patients: Implementation of the tool predicting poor medication adherence with collaborative interviewing

Acronym

Self-care support of diabetic patients by community pharmacists using the tool predicting poor medication adherence

Scientific Title

Individualized intervention by community pharmacists for supporting self-care of diabetic patients: Implementation of the tool predicting poor medication adherence with collaborative interviewing

Scientific Title:Acronym

Self-care support of diabetic patients by community pharmacists using the tool predicting poor medication adherence

Region

Japan


Condition

Condition

Type 2 diabetic patients

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine psychosocial metrics, treatment attitude and behavior, and QOL of the diabetic patients who receive individualized intervention from community pharmacists via collaborative interviewing.

Basic objectives2

Others

Basic objectives -Others

Treatment attitude and behavior

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Problem areas in Diabetes (PAID) Score (at the 6th and 12th month)

Key secondary outcomes

- HbA1c
- QOL (EU-5D-5L,VAS)
- Medication Adherence
- Treatment motivation
All the above items to be evaluated at the 6th and 12th month.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Community pharmacists examine in advance the probability of poor medication adherence of subjects using a newly developed "Risk predicting tool for medication adherence" and implement self-care support depending on each subject's profile of illness insight. In principle, intervention is to be executed at the time when subjects visit community pharmacies for 6 to 12 months. The number of interventions (collaborative interviewing) differ for each subject.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Type 2 diabetic patients who receive outpatient medication and meet the following:
(1) To have had at least 6 months, but not more than 10 years, since the medical treatment for diabetes initiated.
(2) To own a diabetes collaboration notebook and agree provision of copies of relevant medical records.
(3) To agree to cooperate with collecting required data; such as filling out the questionnaires at the start, 6th, and 12th month, responding to interviewing and phone-contacting.

Key exclusion criteria

Among the subjects who satisfy the inclusion criteria, those who able unable to communicate, read, and write in the Japanese language.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Mayumi Mochizuki

Organization

Keio University, Faculty of Pharmacy

Division name

Division of Hospital Pharmacy Science

Zip code


Address

1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan

TEL

03-5400-2486

Email

mochizuki-my@pha.keio.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshiko Tominaga

Organization

Keio University, Faculty of Pharmacy

Division name

Division of Hospital Pharmacy Science

Zip code


Address

1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan

TEL

03-5400-2486

Homepage URL


Email

y-tominaga.pha@keio.jp


Sponsor or person

Institute

Keio University, Faculty of Pharmacy, Division of Hospital Pharmacy Science

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ツルハ薬局17軒(東京、山梨、茨城、神奈川)、なの花薬局5軒(東京、神奈川、静岡)、上田薬剤師会会員薬局9軒(長野)、市民調剤薬局1軒(新潟)、総合メディカル14軒(岩手、福島、宮城、茨城、群馬、栃木、埼玉、千葉、東京、神奈川、静岡、富山)、さくら薬局13軒(茨城、栃木、群馬)、ホームケアファーマシー1軒(鹿児島)



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 10 Month 20 Day

Date of IRB

2017 Year 10 Month 20 Day

Anticipated trial start date

2018 Year 03 Month 12 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 11 Day

Last modified on

2021 Year 03 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036169


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name